ReNeuroGen
Elm Grove
About ReNeuroGen
ReNeuroGen is a virtual pharmaceutical company developing systems pharmacology therapies with a focus on neurological and pulmonary disease indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $75.0K
- Last round: Grant (Jan 2022)
- Website: rngen.com
- Phone: 1-412-972-0134
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/reneurogen-174024 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.